Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature

Dihydropyrimidine dehydrogenase (DPD) is the major enzyme in the catabolism of 5-Fluorouracil (5-FU) and its prodrug capecitabine. We report cases from our institute with colorectal cancer who experienced severe toxicities to standard dose 5-FU based chemotherapy. DPYD gene sequencing revealed rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhari, Nedal, Alshangiti, Abdulraheem, Tashkandi, Emad, Algarni, Mohammed, Al-Shamsi, Humaid O., Al-Khallaf, Hamoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395516/
https://www.ncbi.nlm.nih.gov/pubmed/34449540
http://dx.doi.org/10.3390/clinpract11030062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395516/
https://www.ncbi.nlm.nih.gov/pubmed/34449540
http://dx.doi.org/10.3390/clinpract11030062

Ejemplares similares